← Back to Analyst Consensus 
AARD Buy
Aardvark Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 18
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 12, 2026 (17 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 26, 2026 | twqshuo ype ovkqylor gootjbyk | maintain | — | — | — |
| Oct 19, 2026 | HC Wainwright & Co. | maintain | Neutral → Neutral | — | 44% |
| Sep 24, 2026 | RBC Capital | reiterate | Sector Perform → Sector Perform | — | 55% |
| Jul 20, 2026 | HC Wainwright & Co. | reiterate | Neutral → Neutral | — | 44% |
| May 15, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 55% |
| May 15, 2026 | BTIG | downgrade | Buy → Neutral | — | 52% |
| May 15, 2026 | Morgan Stanley | downgrade | Equal-Weight → Underweight | — | 54% |
| Mar 24, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Mar 2, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Mar 2, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Mar 2, 2026 | Morgan Stanley | downgrade | Overweight → Equal-Weight | — | 54% |
| Mar 2, 2026 | HC Wainwright & Co. | downgrade | Buy → Neutral | — | 44% |
| Mar 2, 2026 | Stifel | downgrade | Buy → Hold | — | 53% |
| Mar 2, 2026 | RBC Capital | downgrade | Outperform → Sector Perform | — | 55% |
| Feb 10, 2026 | BTIG | reiterate | Buy → Buy | $26 | 52% |
| Feb 9, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Dec 23, 2025 | Oppenheimer | initiate | — → Outperform | $35 | 52% |
| Dec 12, 2025 | William Blair | initiate | — → Outperform | $0 | 48% |
| Nov 14, 2025 | RBC Capital | maintain | Outperform → Outperform | $18 | 55% |
| Nov 7, 2025 | BTIG | initiate | — → Buy | $26 | 52% |
| Oct 1, 2025 | Jones Trading | initiate | — → Buy | $33 | 50% |
| Sep 29, 2025 | Stifel | initiate | — → Buy | $24 | 53% |
| Sep 23, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Aug 28, 2025 | B of A Securities | maintain | Buy → Buy | $25 | 53% |
| Aug 14, 2025 | RBC Capital | maintain | Outperform → Outperform | $19 | 55% |
| Jun 30, 2025 | HC Wainwright & Co. | initiate | — → Buy | $40 | 44% |
| May 15, 2025 | RBC Capital | maintain | Outperform → Outperform | $20 | 55% |
| Apr 1, 2025 | RBC Capital | reiterate | Outperform → Outperform | $21 | 55% |
| Apr 1, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $50 | 50% |
| Mar 27, 2025 | B of A Securities | maintain | Buy → Buy | $26 | 53% |
| Mar 10, 2025 | RBC Capital | initiate | — → Outperform | $21 | 55% |
| Mar 10, 2025 | Cantor Fitzgerald | initiate | — → Overweight | $50 | 50% |
| Mar 10, 2025 | Morgan Stanley | initiate | — → Overweight | $29 | 54% |
| Mar 10, 2025 | B of A Securities | initiate | — → Buy | $22 | 53% |
Price Target Trend
May 21, 2026 Oct 26, 2026
EPS Estimates
+1y —
0q —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days